Cargando…

A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?

Objective: To evaluate the effectiveness of a sequenced drug knowledge pilot in third professional year students in a capstone course. Methods: A three-phase drug knowledge pilot was conducted in spring 2022. Students completed a total of thirteen assessments, including nine low-stakes quizzes, thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjoquist, Laura K., Surowiec, Suzanne M., Guy, Jason W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204493/
https://www.ncbi.nlm.nih.gov/pubmed/37218967
http://dx.doi.org/10.3390/pharmacy11030085
_version_ 1785045847017259008
author Sjoquist, Laura K.
Surowiec, Suzanne M.
Guy, Jason W.
author_facet Sjoquist, Laura K.
Surowiec, Suzanne M.
Guy, Jason W.
author_sort Sjoquist, Laura K.
collection PubMed
description Objective: To evaluate the effectiveness of a sequenced drug knowledge pilot in third professional year students in a capstone course. Methods: A three-phase drug knowledge pilot was conducted in spring 2022. Students completed a total of thirteen assessments, including nine low-stakes quizzes, three formative tests, and a final summative comprehensive exam. Results from the previous year’s cohort (historical control) who only completed a summative comprehensive exam were compared to the pilot (test group) results to assess effectiveness. The faculty spent over 300 h developing content for the test group. Results: The pilot group had a mean score of 80.9% on the final competency exam, which was one percent lower than the control group who had a less rigorous intervention. A sub-analysis was conducted that removed the students who failed (<73%) the final competency exam, and no significant difference in the exam score was found. One practice drug exam was found to be moderately correlated and significant (r = 0.62) with the final knowledge exam performance in the control. The number of attempts on the low-stakes assessments had a low correlation with the final exam score in the test group compared to the control (r = 0.24). Conclusion: The results of this study suggest a need to further investigate the best practices for knowledge-based drug characteristic assessments.
format Online
Article
Text
id pubmed-10204493
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102044932023-05-24 A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane? Sjoquist, Laura K. Surowiec, Suzanne M. Guy, Jason W. Pharmacy (Basel) Brief Report Objective: To evaluate the effectiveness of a sequenced drug knowledge pilot in third professional year students in a capstone course. Methods: A three-phase drug knowledge pilot was conducted in spring 2022. Students completed a total of thirteen assessments, including nine low-stakes quizzes, three formative tests, and a final summative comprehensive exam. Results from the previous year’s cohort (historical control) who only completed a summative comprehensive exam were compared to the pilot (test group) results to assess effectiveness. The faculty spent over 300 h developing content for the test group. Results: The pilot group had a mean score of 80.9% on the final competency exam, which was one percent lower than the control group who had a less rigorous intervention. A sub-analysis was conducted that removed the students who failed (<73%) the final competency exam, and no significant difference in the exam score was found. One practice drug exam was found to be moderately correlated and significant (r = 0.62) with the final knowledge exam performance in the control. The number of attempts on the low-stakes assessments had a low correlation with the final exam score in the test group compared to the control (r = 0.24). Conclusion: The results of this study suggest a need to further investigate the best practices for knowledge-based drug characteristic assessments. MDPI 2023-05-13 /pmc/articles/PMC10204493/ /pubmed/37218967 http://dx.doi.org/10.3390/pharmacy11030085 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Sjoquist, Laura K.
Surowiec, Suzanne M.
Guy, Jason W.
A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?
title A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?
title_full A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?
title_fullStr A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?
title_full_unstemmed A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?
title_short A Pharmacy Drug Knowledge Assessment Pilot: Who Will Fly Farthest and What Downs the Plane?
title_sort pharmacy drug knowledge assessment pilot: who will fly farthest and what downs the plane?
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204493/
https://www.ncbi.nlm.nih.gov/pubmed/37218967
http://dx.doi.org/10.3390/pharmacy11030085
work_keys_str_mv AT sjoquistlaurak apharmacydrugknowledgeassessmentpilotwhowillflyfarthestandwhatdownstheplane
AT surowiecsuzannem apharmacydrugknowledgeassessmentpilotwhowillflyfarthestandwhatdownstheplane
AT guyjasonw apharmacydrugknowledgeassessmentpilotwhowillflyfarthestandwhatdownstheplane
AT sjoquistlaurak pharmacydrugknowledgeassessmentpilotwhowillflyfarthestandwhatdownstheplane
AT surowiecsuzannem pharmacydrugknowledgeassessmentpilotwhowillflyfarthestandwhatdownstheplane
AT guyjasonw pharmacydrugknowledgeassessmentpilotwhowillflyfarthestandwhatdownstheplane